Latest updates for Hcbrx

Fresh curated links around HCBRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Inhibrx Biosciences: The Whole Story Rides On INBRX-106
  • Going Deeper On Disc Medicine
  • Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /4 weeks ago

Inhibrx Biosciences: The Whole Story Rides On INBRX-106

Read source
seekingalpha.com /1 month ago

Going Deeper On Disc Medicine

Read source
seekingalpha.com /1 month ago

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

Read source
seekingalpha.com /1 month ago

Hutchmed: Bullish On Their Commercial Prospects And Pipeline Catalysts

Read source
seekingalpha.com /1 month ago

ImmunityBio: Intriguing Progress, If Not (Yet) Commercially - Still A Hold

Read source
valueresearchonline.com /3 weeks ago

Prognosis? Improving

HCG has spent years expanding its cancer hospital network. Now utilisation, margins and returns may improve. Is the valuation discount an opportunity?

Read source
qchron.com /4 days ago

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026

Read source
seekingalpha.com /1 month ago

Helus Pharma: APPROACHing Inflection: Pivotal Readout Sets Up Asymmetric Upside

Read source
seekingalpha.com /1 month ago

Harbor Core Bond Fund Q1 2026 Commentary

Read source
fool.com /1 week ago

Recursion (RXRX) Q2 2026 Earnings Call Transcript

AI-native drug discovery advances neuroscience target with Roche while cutting cash guidance.

Read source
seekingalpha.com /1 week ago

Black Rock Coffee Bar, Inc. (BRCB) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /3 weeks ago

H2O America (HTO) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /6 days ago

Healius Limited (PHCRF) Q4 2026 Earnings Call Transcript

Read source
seekingalpha.com /5 days ago

Heidelberger Druckmaschinen Aktiengesellschaft (HBGRY) Q1 2027 Earnings Call Transcript

Read source
fool.com /6 days ago

Bicara Therapeutics (BCAX) Q2 2026 Earnings Call Transcript

Cash runway extends to 2029 as ficerafusp alfa advances toward interim analysis.

Read source
cafepharma.com /1 month ago

Hoechst-Roussel

Hoechst-Roussel Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/hoechst-roussel.12347/...

Read source
seekingalpha.com /1 month ago

HCA Healthcare, Inc. (HCA) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 week ago

RXO, Inc. (RXO) Presents at Deutsche Bank's Chicago Industrials Summit Transcript

Read source
seekingalpha.com /2 days ago

TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors

Read source
fool.com /1 week ago

Heron (HRTX) Q2 2026 Earnings Call Transcript

Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year.

Read source
seekingalpha.com /1 month ago

Hansa Biopharma AB (publ) (HNSBF) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /2 weeks ago

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Caution Suggested For Chiron Real Estate Preferred Stock, Particularly Series B

Read source
seekingalpha.com /1 month ago

Home Bancorp, Inc. (HBCP) Q2 2026 Earnings Call Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Hcbrx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

qchron.com

Recent coverage from public sources
Public source

valueresearchonline.com

Recent coverage from public sources
Public source